Morphosys AG (DE:MOR)

Morphosys (MOR) Financial Statements


Morphosys Financial Overview

Morphosys's market cap is currently ―. The company's EPS TTM is €-12.754; its P/E ratio is -5.31; Morphosys is scheduled to report earnings on August 29, 2024, and the estimated EPS forecast is €-2.58. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--€ 95.70M€ 59.44M€ 41.47M
Gross Profit--€ 87.70M€ 42.20M€ 33.57M
EBIT--€ 44.50M€ -53.87M€ -59.83M
EBITDA--€ 44.50M€ -51.29M€ -57.26M
Net Income Common Stockholders--€ -122.90M€ -234.99M€ -122.65M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 158.50M€ 5.35M€ 0.00€ 726.83M€ 855.47M
Total Assets€ 2.03B€ 2.40B-€ 2.51B€ 2.46B
Total Debt€ 256.45M€ 339.46M€ 0.00€ 331.94M€ 328.15M
Net Debt€ 97.95M€ 334.11M€ 0.00€ -394.89M€ -527.32M
Total Liabilities€ 1.98B€ 2.24B-€ 2.54B€ 2.32B
Stockholders Equity€ 49.05M€ 7.85M€ 0.00€ -27.46M€ 141.74M
Cash Flow-
Free Cash Flow---€ -97.74M€ -144.98M
Operating Cash Flow---€ -94.20M€ -143.81M
Investing Cash Flow---€ 98.82M€ 115.19M
Financing Cash Flow---€ 1.94M€ 13.77M
Currency in EUR

Morphosys Earnings and Revenue History

Morphosys Debt to Assets

Morphosys Cash Flow

Morphosys Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis